Skip to main content
Atrás
Watch Compare

IceCure Medical Ltd.

Calidad de datos: 100%
ICCM
Nasdaq Manufacturing Measuring & Analyzing Instruments
$0.34
▲ $0.01 (1.72%)
Cap. Mercado: 27.88 M
Precio
$0.34
Cap. Mercado
27.88 M
Rango del Día
$0.34 — $0.36
Rango de 52 Semanas
$0.28 — $1.40
Volumen
282,557
Apertura $0.34
Promedio 50D / 200D
$0.57
40.14% below
Promedio 50D / 200D
$0.79
56.38% below

Quick Summary

Puntos Clave

Revenue declined -4.94% annually over 5 years
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -14.61 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.61%
Capital efficient — spends only 1.07% of revenue on capex

Crecimiento

Revenue Growth (5Y)
-4.94%
Below sector avg (1.82%)
Revenue (1Y)2.67%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-223.05%
Below sector avg (-53.41%)
ROIC-172.45%
Net Margin-445.61%
Op. Margin-446.70%

Seguridad

Debt / Equity
0.02
Below sector avg (0.31)
Current Ratio1.18
Interest CoverageN/A

Valoración

PE (TTM)
-1.85
Below sector avg (-1.48)
P/B Ratio9.64
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -1.9 -1.5
P/B 9.6 1.6
ROE % -223.1 -53.4
Net Margin % -445.6 -41.5
Rev Growth 5Y % -4.9 1.8
D/E 0.0 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 2.67% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -4.94% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3.38 M Net Income (TTM) -15.06 M
ROE -223.05% ROA -116.06%
Gross Margin 36.28% Operating Margin -446.70%
Net Margin -445.61% Free Cash Flow (TTM) -14.61 M
ROIC -172.45% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.02 Current Ratio 1.18
Interest Coverage N/A Asset Turnover 0.26
Working Capital 1.38 M Tangible Book Value 2.89 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.85 Forward P/E N/A
P/B Ratio 9.64 P/S Ratio 8.25
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -52.41%
Market Cap 27.88 M Enterprise Value 22.55 M
Per Share
EPS (Diluted TTM) 0.24 Revenue / Share 0.04
FCF / Share -0.18 OCF / Share -0.18
EPS CAGR (1Y) -20.00% EPS CAGR (5Y) -9.00%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.07% FCF Conversion 97.03%
SBC-Adj. FCF -16.87 M Growth Momentum 7.61

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.38 M 3.29 M — 3.09 M 4.14 M
Net Income -15.06 M -15.32 M -14.65 M -16.98 M -9.90 M
EPS (Diluted) 0.24 0.30 0.32 0.46 0.35
Gross Profit 1.23 M 1.45 M 1.30 M 1.45 M 2.20 M
Operating Income -15.09 M -15.70 M -15.58 M -16.74 M 9.72 M
EBITDA — — — — —
R&D Expenses 7.43 M 7.10 M 8.27 M 9.12 M 5.88 M
SG&A Expenses — — — 735,000.0 177,000.0
D&A — — — — —
Interest Expense — — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 13.89 M 12.58 M 16.41 M 30.19 M 32.28 M
Total Liabilities — — — — —
Shareholders' Equity 9.05 M 6.90 M 12.16 M 25.42 M 26.96 M
Total Debt 13,000.0 — — — —
Cash & Equivalents 8.90 M 7.56 M 10.53 M 23.66 M 25.62 M
Current Assets 12.61 M 10.75 M 14.18 M 28.13 M 30.32 M
Current Liabilities 4.82 M 5.51 M 3.87 M 4.34 M 4.02 M